![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/as-monsoon-sets-in-respiratory-malaria-drugs-see-demand-rise/articleshow/111560158.cms
https://www.glenmarklifesciences.com/pdf/Press%20Release_Glenmark%20Life%20Sciences_Q4%20FY24%20Results_V3.pdf
https://www.glenmarklifesciences.com/pdf/Press%20Release_Nirma%20acquires%20majority%20stake_GLS_March%2012_2024.pdf
https://www.indianpharmapost.com/news/nirma-acquires-majority-stake-in-glenmark-life-sciences-15386
https://www.glenmarklifesciences.com/pdf/Press%20Release_Glenmark%20Life%20Sciences_Q3%20FY24%20Results.pdf
https://www.indianpharmapost.com/news/glenmark-life-sciences-inks-cdmo-supply-deal-with-a-japanese-pharma-innovator-15172
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-launches-triple-drug-combo-for-type-2-diabetes/articleshow/104518130.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-gets-usfda-nod-to-market-generic-diabetes-drug/articleshow/102302377.cms
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nirma-closes-in-on-glenmarks-api-arm-emerges-sole-contender-as-bid-deadline-ends/articleshow/102258230.cms
https://www.indianpharmapost.com/news/glenmark-life-sciences-reports-robust-25-ebitda-growth-in-q1fy24-14417